Maternal care for anti-D [Rh] antibodies, second trimester (fetus 4)
ICD-10 O36.0124 is a billable code used to indicate a diagnosis of maternal care for anti-d [rh] antibodies, second trimester (fetus 4).
O36.0124 refers to maternal care for a pregnancy complicated by the presence of anti-D (Rh) antibodies during the second trimester, specifically for the fourth fetus. This condition arises when an Rh-negative mother produces antibodies against Rh-positive fetal blood cells, which can lead to hemolytic disease of the newborn (HDN) if not monitored and managed appropriately. The presence of these antibodies can result in fetal complications such as growth restriction, fetal distress, and even fetal demise if the condition is severe. Regular monitoring through ultrasound and Doppler studies is essential to assess fetal well-being, including growth patterns and blood flow. Maternal care may involve additional interventions such as Rh immunoglobulin administration to prevent further antibody production and close surveillance of fetal health through non-stress tests and biophysical profiles. The management of this condition requires a multidisciplinary approach, often involving obstetricians and maternal-fetal medicine specialists to ensure optimal outcomes for both mother and fetus.
Detailed records of maternal health, fetal monitoring, and any interventions performed.
Management of Rh sensitization, monitoring for fetal growth restriction, and addressing fetal distress.
Accurate coding requires understanding of the implications of Rh incompatibility and its management.
Comprehensive documentation of high-risk factors, ultrasound findings, and treatment protocols.
Complex cases involving multiple pregnancies, severe fetal anemia, or intrauterine transfusions.
High-risk pregnancies necessitate thorough documentation of all assessments and interventions.
Used for monitoring fetal growth and well-being in pregnancies complicated by anti-D antibodies.
Documentation must include indications for the ultrasound and findings related to fetal health.
Obstetricians should ensure that ultrasound findings are clearly linked to the diagnosis of anti-D antibodies.
Having anti-D antibodies can lead to serious fetal complications, including hemolytic disease of the newborn. It is crucial for healthcare providers to monitor the pregnancy closely and manage any arising complications to ensure the health of both mother and fetus.
